Seres Therapeutics Inc (NAS:MCRB)
$ 0.7589 -0.017 (-2.19%) Market Cap: 114.94 Mil Enterprise Value: 221.66 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 49/100

Seres Therapeutics Inc Annual Shareholders Meeting Transcript

Jun 18, 2020 / 12:00PM GMT
Release Date Price: $4.4 (-6.78%)
Thomas J. DesRosier
Seres Therapeutics, Inc. - Chief Legal Officer, Executive VP & Secretary

Good morning, everyone. I'm Tom DesRosier, Executive Vice President.

Caroline Holda
Seres Therapeutics, Inc. - Assistant General Counsel

Good morning. This is Caroline Holda. I'm going to take over as I don't hear Tom's voice. I am the Assistant Secretary and Assistant General Counsel of Seres Therapeutics and the Deputy Chairperson of today's meeting. I'm very happy to welcome you to our 2020 Annual Meeting of Shareholders, which we are holding virtually in light of the COVID-19 pandemic.

Before the meeting is called to order, I'd like to introduce you to the members of the Board and the other Executive Officers of the company who are on the webcast today. From the Board, we have Eric Shaff, President and Chief Executive Officer of Seres; Stephen Berenson, Chairman of the Board; Dennis Ausiello; Grégory Behar; Paul Biondi; Willard Dere; Kurt Graves; Richard Kender; and Meryl Zausner.

From the company, we also have John Aunins, our Chief

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot